389.30
405.05
387.00
635.00
31.60
3,447.05
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Current Price
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Aarti Drugs Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 5,768.98 crores, it is incorporated in the year 1984. It features consolidated sales of Rs. 579.95 crores in June 2021. It is also listed in the Bombay Stock Exchange (BSE) with the code 524348 and listed in the National Stock Exchange (NSE) with the code AARTIDRUGS.
Aarti Drugs Ltd was incorporated as a private limited company on 28th September ’1984 and converted into a public limited company in 1992. It is owned by Aarti Industries Ltd, which also owns a Research & Development plant in Tarapur, Maharashtra. The Company is engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. The Company operates through eight manufacturing facilities, two of which are strategically located in the state of Gujarat and Maharashtra. Also, all the manufacturing units of Aarti Industries are GMP certified, and therefore, the Company is additionally in the process of acquiring certification as per ISO 9002 compliance standard for all its units, out of which one has received the certification. The promoters of the Company currently hold 60.14% of the stake in the Company, while the Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) hold 2.57% and 2% of the stake. The balance of 35.29% is held by others (retail investors).
In June 2021, quarterly net sales were Rs. 505.79 crores, which has increased by approximately 6.36% from Rs. 475.55 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 45.54 crores, which has fallen by 37.64% from a net profit of Rs. 73.03 crores in June 2020. In June 2021, the operating profit was Rs. 429.79 crores, which is also increased by 3.51% as compared to the operating profit of Rs. 415.22 crores for the quarter ending in June 2020. From Rs. 31.34 in June 2020, the EPS of Aarti Drugs has been reduced to just Rs. 4.9 per share in June 2021. AARTIDRUGS’s stock closed at Rs. 634.80 on 16th August’2021 (NSE) and has returned -1.50% in the last six months and -70.23% in the last year.
Aarti Drugs share price as on 11 Feb 2025 is Rs. 393.95. Over the past 6 months, the Aarti Drugs share price has decreased by 23.52% and in the last one year, it has decreased by 24.98%. The 52-week low for Aarti Drugs share price was Rs. 387 and 52-week high was Rs. 635.
524348
AARTIDRUGS
INE767A01016
Sep
You can buy Aarti Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 11, 2025 03:58 PM the closing price of Aarti Drugs Ltd was Rs.393.95.
The latest PE ratio of Aarti Drugs Ltd as of Feb 11, 2025 03:58 PM is 24.37
The latest PB ratio of Aarti Drugs Ltd as of Feb 11, 2025 03:58 PM is 0.34
The 52-week high of Aarti Drugs Ltd share price is Rs. 635.00 while the 52-week low is Rs. 387.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 11, 2025 03:58 PM, the market cap of Aarti Drugs Ltd stood at Rs. 3,595.58 Cr.
We appreciate your patience. Your content is on the way.